Carla-Marie Hayden
Medical · Shelby Twp, MINPI 1427718758
Payments from drug & device makers
Across 236 payments — averaging $18.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$745
- Lilly USA, LLC$578
- Medtronic$410
- Sanofi-aventis U.S. LLC$307
- Corcept Therapeutics$277
- Boehringer Ingelheim$238
- plus $2K from 30 others
What the payments were for
- Food & beverage$4,425100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 52 | $745 |
| Lilly USA, LLC | 33 | $578 |
| Medtronic | 19 | $410 |
| Sanofi-aventis U.S. LLC | 11 | $307 |
| Corcept Therapeutics | 13 | $277 |
| Boehringer Ingelheim | 8 | $238 |
| Bayer | 9 | $185 |
| Amgen | 10 | $182 |
| Amneal Pharmaceuticals LLC | 10 | $174 |
| Xeris Pharmaceuticals, Inc. | 9 | $170 |
| Mannkind Corporation | 7 | $117 |
| Antares Pharma, Inc. | 5 | $111 |
| Recordati_rare_diseases_inc. | 4 | $108 |
| IBSA Pharma Inc. | 4 | $70 |
| Halozyme Inc | 3 | $60 |
| Dexcom, Inc. | 3 | $60 |
| Ascendis Pharma Endocrinology Inc | 3 | $59 |
| Amryt Pharma Holdings Ltd | 4 | $56 |
| Radius Health, Inc. | 3 | $53 |
| BETA Bionics, Inc. | 3 | $47 |
| Neurocrine Biosciences, Inc. | 2 | $47 |
| Insulet Corporation | 2 | $45 |
| Alvogen Inc | 2 | $37 |
| Chiesi USA, Inc. | 2 | $35 |
| Acella Pharmaceuticals, LLC | 2 | $32 |
| RGH Enterprises LLC | 1 | $30 |
| AstraZeneca | 2 | $29 |
| Sequel Med Tech, LLC | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $19 |
| Amphastar Pharmaceuticals, Inc. | 1 | $18 |
| Tolmar, Inc. | 1 | $17 |
| Lifescan, Inc. | 1 | $13 |
| Theracosbio, LLC | 2 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,425 in reported general payments places this provider in the 85th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 188 | $248,582 |
| OzempicSemaglutide | 99 | $190,338 |
| MounjaroTirzepatide | 101 | $183,515 |
| TrulicityDulaglutide | 59 | $96,882 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 28 | $36,267 |
| FarxigaDapagliflozin Propanediol | 17 | $27,217 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $19,297 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $19,203 |
| JanuviaSitagliptin Phosphate | 15 | $16,305 |
| Novolog FlexpenInsulin Aspart | 29 | $11,165 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 55 | $10,130 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 12 | $9,238 |
| Humalog Kwikpen U-100Insulin Lispro | 15 | $6,435 |
| SynjardyEmpagliflozin/Metformin Hcl | 14 | $4,957 |
| LantusInsulin Glargine,hum.Rec.Anlog | 11 | $2,753 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy | $238 | $289,806230 claims |
| Lilly USA, LLCMounjaro, Trulicity | $578 | $280,398160 claims |
| Novo NordiskOzempic | $745 | $190,33899 claims |
| AstraZenecaFarxiga | $29 | $27,21717 claims |
| Sanofi-aventis U.S. LLCLantus | $307 | $2,75311 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $174 | $2,241155 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 755 medical providers in Michigan.
Other medical in Shelby Twp
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Meredith KentGrand Rapids$192K
- Amber ShullNorton Shores$154K
- Jason EvansWaterford$104K
- James ToreySaint Clair Shores$66K
- David WilkinsMuskegon$41K
- Mark RosenBerkley$32K
- Robert DemeesterRoyal Oak$27K
- John BrabantDetroit$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.